{"frames":[{"target":{"name":"Medical_specialties","spans":[{"start":1,"end":2,"text":"medicine"}]},"annotationSets":[{"rank":0,"score":4.867614713043204,"frameElements":[{"name":"Specialty","spans":[{"start":0,"end":2,"text":"Nature medicine"}]}]}]}],"tokens":["Nature","medicine","."]}
{"frames":[{"target":{"name":"Building_subparts","spans":[{"start":4,"end":5,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.708497539293926,"frameElements":[{"name":"Building_part","spans":[{"start":4,"end":5,"text":"cell"}]}]}]},{"target":{"name":"Biological_urge","spans":[{"start":5,"end":6,"text":"exhaustion"}]},"annotationSets":[{"rank":0,"score":38.065619383377474,"frameElements":[]}]},{"target":{"name":"Causation","spans":[{"start":6,"end":7,"text":"induced"}]},"annotationSets":[{"rank":0,"score":62.20141273086059,"frameElements":[{"name":"Cause","spans":[{"start":3,"end":6,"text":"T cell exhaustion"}]},{"name":"Effect","spans":[{"start":7,"end":14,"text":"by tonic signaling of chimeric antigen receptors"}]}]}]}],"tokens":["4-1BB","costimulation","ameliorates","T","cell","exhaustion","induced","by","tonic","signaling","of","chimeric","antigen","receptors","."]}
{"frames":[{"target":{"name":"Vehicle","spans":[{"start":4,"end":5,"text":"CARs"}]},"annotationSets":[{"rank":0,"score":28.672850180462852,"frameElements":[{"name":"Vehicle","spans":[{"start":4,"end":5,"text":"CARs"}]}]}]},{"target":{"name":"Purpose","spans":[{"start":6,"end":7,"text":"targeting"}]},"annotationSets":[{"rank":0,"score":35.869372419990846,"frameElements":[{"name":"Goal","spans":[{"start":7,"end":16,"text":"CD19 have mediated dramatic antitumor responses in hematologic malignancies"}]}]}]},{"target":{"name":"Response","spans":[{"start":12,"end":13,"text":"responses"}]},"annotationSets":[{"rank":0,"score":44.730655779457315,"frameElements":[{"name":"Response","spans":[{"start":13,"end":16,"text":"in hematologic malignancies"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":18,"end":19,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Event","spans":[{"start":22,"end":23,"text":"occurred"}]},"annotationSets":[{"rank":0,"score":33.40204810655341,"frameElements":[{"name":"Event","spans":[{"start":23,"end":28,"text":"using CARs targeting other antigens"}]}]}]},{"target":{"name":"Using","spans":[{"start":23,"end":24,"text":"using"}]},"annotationSets":[{"rank":0,"score":101.97804862344915,"frameElements":[{"name":"Instrument","spans":[{"start":24,"end":28,"text":"CARs targeting other antigens"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":24,"end":25,"text":"CARs"}]},"annotationSets":[{"rank":0,"score":28.31201598667945,"frameElements":[{"name":"Vehicle","spans":[{"start":24,"end":25,"text":"CARs"}]}]}]},{"target":{"name":"Purpose","spans":[{"start":25,"end":26,"text":"targeting"}]},"annotationSets":[{"rank":0,"score":35.16646754077745,"frameElements":[{"name":"Agent","spans":[{"start":24,"end":25,"text":"CARs"}]}]}]},{"target":{"name":"Increment","spans":[{"start":26,"end":27,"text":"other"}]},"annotationSets":[{"rank":0,"score":19.58811385416116,"frameElements":[{"name":"Class","spans":[{"start":27,"end":28,"text":"antigens"}]}]}]}],"tokens":["Chimeric","antigen","receptors","-LRB-","CARs","-RRB-","targeting","CD19","have","mediated","dramatic","antitumor","responses","in","hematologic","malignancies",",","but","tumor","regression","has","rarely","occurred","using","CARs","targeting","other","antigens","."]}
{"frames":[{"target":{"name":"State_continue","spans":[{"start":1,"end":2,"text":"remains"}]},"annotationSets":[{"rank":0,"score":28.592254892370562,"frameElements":[{"name":"State","spans":[{"start":2,"end":3,"text":"unknown"}]},{"name":"Entity","spans":[{"start":0,"end":1,"text":"It"}]}]}]},{"target":{"name":"Awareness","spans":[{"start":2,"end":3,"text":"unknown"}]},"annotationSets":[{"rank":0,"score":64.57644611078983,"frameElements":[{"name":"Content","spans":[{"start":3,"end":29,"text":"whether the impressive effects of CD19 CARs relate to greater susceptibility of hematologic malignancies to CAR therapies , or superior functionality of the CD19 CAR itself"}]},{"name":"Cognizer","spans":[{"start":0,"end":1,"text":"It"}]}]}]},{"target":{"name":"Stimulus_focus","spans":[{"start":5,"end":6,"text":"impressive"}]},"annotationSets":[{"rank":0,"score":34.82609969894162,"frameElements":[{"name":"Stimulus","spans":[{"start":6,"end":7,"text":"effects"}]}]}]},{"target":{"name":"Objective_influence","spans":[{"start":6,"end":7,"text":"effects"}]},"annotationSets":[{"rank":0,"score":39.639091598299665,"frameElements":[{"name":"Degree","spans":[{"start":5,"end":6,"text":"impressive"}]},{"name":"Influencing_situation","spans":[{"start":7,"end":10,"text":"of CD19 CARs"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":9,"end":10,"text":"CARs"}]},"annotationSets":[{"rank":0,"score":28.03431106489548,"frameElements":[{"name":"Vehicle","spans":[{"start":9,"end":10,"text":"CARs"}]}]}]},{"target":{"name":"Statement","spans":[{"start":10,"end":11,"text":"relate"}]},"annotationSets":[{"rank":0,"score":106.88961254198247,"frameElements":[{"name":"Speaker","spans":[{"start":4,"end":10,"text":"the impressive effects of CD19 CARs"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":18,"end":19,"text":"CAR"}]},"annotationSets":[{"rank":0,"score":28.707687128858833,"frameElements":[{"name":"Vehicle","spans":[{"start":18,"end":19,"text":"CAR"}]}]}]},{"target":{"name":"Cure","spans":[{"start":19,"end":20,"text":"therapies"}]},"annotationSets":[{"rank":0,"score":54.11632615959025,"frameElements":[]}]},{"target":{"name":"Vehicle","spans":[{"start":27,"end":28,"text":"CAR"}]},"annotationSets":[{"rank":0,"score":27.668392860403742,"frameElements":[{"name":"Vehicle","spans":[{"start":27,"end":28,"text":"CAR"}]}]}]}],"tokens":["It","remains","unknown","whether","the","impressive","effects","of","CD19","CARs","relate","to","greater","susceptibility","of","hematologic","malignancies","to","CAR","therapies",",","or","superior","functionality","of","the","CD19","CAR","itself","."]}
{"frames":[{"target":{"name":"Reasoning","spans":[{"start":1,"end":2,"text":"show"}]},"annotationSets":[{"rank":0,"score":57.5547771466565,"frameElements":[{"name":"Content","spans":[{"start":2,"end":31,"text":"that tonic CAR CD3-zeta , phosphorylation , triggered by antigen-independent clustering of CAR single-chain variable fragments , can induce early exhaustion of CAR T cells that limits antitumor efficacy"}]},{"name":"Arguer","spans":[{"start":0,"end":1,"text":"We"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":4,"end":5,"text":"CAR"}]},"annotationSets":[{"rank":0,"score":28.950605886038325,"frameElements":[{"name":"Vehicle","spans":[{"start":4,"end":5,"text":"CAR"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":14,"end":15,"text":"CAR"}]},"annotationSets":[{"rank":0,"score":28.932215313674373,"frameElements":[{"name":"Vehicle","spans":[{"start":14,"end":15,"text":"CAR"}]}]}]},{"target":{"name":"Contingency","spans":[{"start":16,"end":17,"text":"variable"}]},"annotationSets":[{"rank":0,"score":13.283703943858736,"frameElements":[]}]},{"target":{"name":"Part_piece","spans":[{"start":17,"end":18,"text":"fragments"}]},"annotationSets":[{"rank":0,"score":12.226425334633998,"frameElements":[{"name":"Substance","spans":[{"start":14,"end":15,"text":"CAR"}]},{"name":"Piece","spans":[{"start":17,"end":18,"text":"fragments"}]}]}]},{"target":{"name":"Capability","spans":[{"start":19,"end":20,"text":"can"}]},"annotationSets":[{"rank":0,"score":40.40290717786808,"frameElements":[{"name":"Event","spans":[{"start":21,"end":31,"text":"early exhaustion of CAR T cells that limits antitumor efficacy"}]},{"name":"Entity","spans":[{"start":14,"end":18,"text":"CAR single-chain variable fragments"}]}]}]},{"target":{"name":"Causation","spans":[{"start":20,"end":21,"text":"induce"}]},"annotationSets":[{"rank":0,"score":69.75540555916247,"frameElements":[{"name":"Cause","spans":[{"start":10,"end":18,"text":"by antigen-independent clustering of CAR single-chain variable fragments"}]},{"name":"Effect","spans":[{"start":21,"end":31,"text":"early exhaustion of CAR T cells that limits antitumor efficacy"}]}]}]},{"target":{"name":"Temporal_collocation","spans":[{"start":21,"end":22,"text":"early"}]},"annotationSets":[{"rank":0,"score":30.19833461184307,"frameElements":[]}]},{"target":{"name":"Biological_urge","spans":[{"start":22,"end":23,"text":"exhaustion"}]},"annotationSets":[{"rank":0,"score":39.136095491628595,"frameElements":[{"name":"Experiencer","spans":[{"start":23,"end":27,"text":"of CAR T cells"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":24,"end":25,"text":"CAR"}]},"annotationSets":[{"rank":0,"score":28.891373258055065,"frameElements":[{"name":"Vehicle","spans":[{"start":24,"end":25,"text":"CAR"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":26,"end":27,"text":"cells"}]},"annotationSets":[{"rank":0,"score":21.473947423565853,"frameElements":[{"name":"Building_part","spans":[{"start":26,"end":27,"text":"cells"}]}]}]}],"tokens":["We","show","that","tonic","CAR","CD3-zeta",",","phosphorylation",",","triggered","by","antigen-independent","clustering","of","CAR","single-chain","variable","fragments",",","can","induce","early","exhaustion","of","CAR","T","cells","that","limits","antitumor","efficacy","."]}
{"frames":[{"target":{"name":"Presence","spans":[{"start":3,"end":4,"text":"present"}]},"annotationSets":[{"rank":0,"score":6.007195785630218,"frameElements":[{"name":"Location","spans":[{"start":4,"end":18,"text":"to varying degrees in all CARs studied , except the highly effective CD19 CAR"}]},{"name":"Entity","spans":[{"start":0,"end":2,"text":"Such activation"}]}]}]},{"target":{"name":"Similarity","spans":[{"start":5,"end":6,"text":"varying"}]},"annotationSets":[{"rank":0,"score":46.680209857533406,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":6,"end":7,"text":"degrees"}]},"annotationSets":[{"rank":0,"score":23.601731909574358,"frameElements":[{"name":"Quantity","spans":[{"start":6,"end":7,"text":"degrees"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":8,"end":9,"text":"all"}]},"annotationSets":[{"rank":0,"score":27.25578578379028,"frameElements":[{"name":"Quantity","spans":[{"start":8,"end":9,"text":"all"}]},{"name":"Individuals","spans":[{"start":9,"end":10,"text":"CARs"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":9,"end":10,"text":"CARs"}]},"annotationSets":[{"rank":0,"score":31.685885100644306,"frameElements":[{"name":"Vehicle","spans":[{"start":9,"end":10,"text":"CARs"}]}]}]},{"target":{"name":"Education_teaching","spans":[{"start":10,"end":11,"text":"studied"}]},"annotationSets":[{"rank":0,"score":82.752528970448,"frameElements":[]}]},{"target":{"name":"Usefulness","spans":[{"start":15,"end":16,"text":"effective"}]},"annotationSets":[{"rank":0,"score":23.00922904194719,"frameElements":[{"name":"Degree","spans":[{"start":14,"end":15,"text":"highly"}]},{"name":"Entity","spans":[{"start":17,"end":18,"text":"CAR"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":17,"end":18,"text":"CAR"}]},"annotationSets":[{"rank":0,"score":28.73134841613163,"frameElements":[{"name":"Vehicle","spans":[{"start":17,"end":18,"text":"CAR"}]}]}]}],"tokens":["Such","activation","is","present","to","varying","degrees","in","all","CARs","studied",",","except","the","highly","effective","CD19","CAR","."]}
{"frames":[{"target":{"name":"Increment","spans":[{"start":1,"end":2,"text":"further"}]},"annotationSets":[{"rank":0,"score":15.01624014207794,"frameElements":[{"name":"Class","spans":[{"start":4,"end":7,"text":"CD28 costimulation augments"}]}]}]},{"target":{"name":"Contingency","spans":[{"start":2,"end":3,"text":"determine"}]},"annotationSets":[{"rank":0,"score":11.111699955725236,"frameElements":[{"name":"Determinant","spans":[{"start":0,"end":1,"text":"We"}]}]}]},{"target":{"name":"Cause_change_of_position_on_a_scale","spans":[{"start":11,"end":12,"text":"reduces"}]},"annotationSets":[{"rank":0,"score":67.76656280435441,"frameElements":[{"name":"Agent","spans":[{"start":9,"end":11,"text":"4-1BB costimulation"}]}]}]},{"target":{"name":"Biological_urge","spans":[{"start":13,"end":14,"text":"exhaustion"}]},"annotationSets":[{"rank":0,"score":39.05053656878541,"frameElements":[]}]},{"target":{"name":"Causation","spans":[{"start":14,"end":15,"text":"induced"}]},"annotationSets":[{"rank":0,"score":68.15809332078022,"frameElements":[{"name":"Effect","spans":[{"start":15,"end":19,"text":"by persistent CAR signaling"}]}]}]},{"target":{"name":"Process_continue","spans":[{"start":16,"end":17,"text":"persistent"}]},"annotationSets":[{"rank":0,"score":37.54678167246281,"frameElements":[{"name":"Event","spans":[{"start":17,"end":18,"text":"CAR"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":17,"end":18,"text":"CAR"}]},"annotationSets":[{"rank":0,"score":28.85688425515537,"frameElements":[{"name":"Vehicle","spans":[{"start":17,"end":18,"text":"CAR"}]}]}]}],"tokens":["We","further","determine","that","CD28","costimulation","augments",",","whereas","4-1BB","costimulation","reduces",",","exhaustion","induced","by","persistent","CAR","signaling","."]}
{"frames":[{"target":{"name":"Causation","spans":[{"start":1,"end":2,"text":"results"}]},"annotationSets":[{"rank":0,"score":74.93785450306031,"frameElements":[{"name":"Cause","spans":[{"start":0,"end":1,"text":"Our"}]}]}]},{"target":{"name":"Supply","spans":[{"start":2,"end":3,"text":"provide"}]},"annotationSets":[{"rank":0,"score":69.73962826720923,"frameElements":[{"name":"Supplier","spans":[{"start":0,"end":2,"text":"Our results"}]},{"name":"Theme","spans":[{"start":3,"end":29,"text":"biological explanations for the antitumor effects of CD19 CARs and for the observations that CD19 CAR T cells incorporating the 4-1BB costimulatory domain are more persistent"}]}]}]},{"target":{"name":"Weapon","spans":[{"start":3,"end":4,"text":"biological"}]},"annotationSets":[{"rank":0,"score":62.31890718588825,"frameElements":[{"name":"Weapon","spans":[{"start":3,"end":4,"text":"biological"}]}]}]},{"target":{"name":"Statement","spans":[{"start":4,"end":5,"text":"explanations"}]},"annotationSets":[{"rank":0,"score":108.21364909099333,"frameElements":[{"name":"Topic","spans":[{"start":5,"end":26,"text":"for the antitumor effects of CD19 CARs and for the observations that CD19 CAR T cells incorporating the 4-1BB costimulatory domain"}]}]}]},{"target":{"name":"Objective_influence","spans":[{"start":8,"end":9,"text":"effects"}]},"annotationSets":[{"rank":0,"score":39.24360772887647,"frameElements":[{"name":"Influencing_situation","spans":[{"start":9,"end":12,"text":"of CD19 CARs"}]}]}]},{"target":{"name":"Vehicle","spans":[{"start":11,"end":12,"text":"CARs"}]},"annotationSets":[{"rank":0,"score":27.734000940370915,"frameElements":[{"name":"Vehicle","spans":[{"start":11,"end":12,"text":"CARs"}]}]}]},{"target":{"name":"Perception_active","spans":[{"start":15,"end":16,"text":"observations"}]},"annotationSets":[{"rank":0,"score":70.49854446797414,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":20,"end":21,"text":"cells"}]},"annotationSets":[{"rank":0,"score":18.860131304634727,"frameElements":[{"name":"Building_part","spans":[{"start":20,"end":21,"text":"cells"}]}]}]},{"target":{"name":"Inclusion","spans":[{"start":21,"end":22,"text":"incorporating"}]},"annotationSets":[{"rank":0,"score":33.070022142822026,"frameElements":[{"name":"Part","spans":[{"start":22,"end":26,"text":"the 4-1BB costimulatory domain"}]},{"name":"Total","spans":[{"start":19,"end":21,"text":"T cells"}]}]}]},{"target":{"name":"Increment","spans":[{"start":27,"end":28,"text":"more"}]},"annotationSets":[{"rank":0,"score":15.57174268582126,"frameElements":[{"name":"Class","spans":[{"start":28,"end":29,"text":"persistent"}]}]}]},{"target":{"name":"Process_continue","spans":[{"start":28,"end":29,"text":"persistent"}]},"annotationSets":[{"rank":0,"score":40.94471222188345,"frameElements":[{"name":"Event","spans":[{"start":3,"end":26,"text":"biological explanations for the antitumor effects of CD19 CARs and for the observations that CD19 CAR T cells incorporating the 4-1BB costimulatory domain"}]}]}]},{"target":{"name":"Inclusion","spans":[{"start":31,"end":32,"text":"incorporating"}]},"annotationSets":[{"rank":0,"score":24.75659120207302,"frameElements":[]}]},{"target":{"name":"Trial","spans":[{"start":35,"end":36,"text":"trials"}]},"annotationSets":[{"rank":0,"score":44.92907091084076,"frameElements":[{"name":"Defendant","spans":[{"start":34,"end":35,"text":"clinical"}]}]}]}],"tokens":["Our","results","provide","biological","explanations","for","the","antitumor","effects","of","CD19","CARs","and","for","the","observations","that","CD19","CAR","T","cells","incorporating","the","4-1BB","costimulatory","domain","are","more","persistent","than","those","incorporating","CD28","in","clinical","trials","."]}
